Literature DB >> 20689963

Photodynamic therapy for polypoidal choroidal vasculopathy.

Jay Kumar Chhablani.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20689963     DOI: 10.1007/s00417-010-1478-7

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  5 in total

1.  Intravitreal bevacizumab alone versus combined verteporfin photodynamic therapy and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration: visual acuity after 1 year of follow-up.

Authors:  Christopher J Rudnisky; Conrad Liu; Mancho Ng; Ezekiel Weis; Matthew T S Tennant
Journal:  Retina       Date:  2010-04       Impact factor: 4.256

2.  Factors influencing visual outcome of polypoidal choroidal vasculopathy one year after photodynamic therapy.

Authors:  Ryusaburo Mori; Mitsuko Yuzawa; Zeon Lee; Miho Haruyama; Eriko Akaza
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-30       Impact factor: 3.117

3.  Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy.

Authors:  Seong-Woo Kim; Jaeryung Oh; In Kyung Oh; Kuhl Huh
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2009 May-Jun

4.  Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results.

Authors:  Gregg T Kokame; Ling Yeung; James C Lai
Journal:  Br J Ophthalmol       Date:  2009-09-01       Impact factor: 4.638

5.  The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy.

Authors:  Sun Young Lee; June Gone Kim; Soo Geun Joe; Hyewon Chung; Young Hee Yoon
Journal:  Korean J Ophthalmol       Date:  2008-06
  5 in total
  3 in total

Review 1.  Baseline Predictors of Visual Acuity Outcome in Patients with Wet Age-Related Macular Degeneration.

Authors:  Xinyuan Zhang; Timothy Y Y Lai
Journal:  Biomed Res Int       Date:  2018-02-26       Impact factor: 3.411

2.  Patient-Perceived Benefit of Treatment in Polypoidal Choroidal Vasculopathy: A Pilot Study.

Authors:  Rituparna Ghoshal; Sharanjeet Sharanjeet-Kaur; Norliza Mohamad Fadzil; Somnath Ghosh; Nor Fariza Ngah; Roslin Azni Abd Aziz
Journal:  Int J Environ Res Public Health       Date:  2020-09-02       Impact factor: 3.390

3.  Visual Parameters and Retinal Morphology for Polypoidal Choroidal Vasculopathy Pre- and Post-Intravitreal Ranibizumab with or without Photodynamic Therapy: A Short-Term Prospective Study.

Authors:  Rituparna Ghoshal; Sharanjeet Sharanjeet-Kaur; Norliza Mohamad Fadzil; Somnath Ghosh; Nor Fariza Ngah; Roslin Azni Binti Abd Aziz
Journal:  Int J Environ Res Public Health       Date:  2021-03-04       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.